Hehe Diagnostics - Market Entry Research for Third-Party Detection Services
Company overview
Hehe Diagnostics was founded in December 2010 and is a state-level high-tech enterprise specializing in third-party medical detection services. With its headquarters in China, the company has established 21 subsidiaries and branches nationwide over the past decade, with its service network covering major regions across the country. Hehe Diagnostics operates more than 200 state-of-the-art laboratory testing instruments and has served over 10 million patients cumulatively. The company has long provided high-quality, differentiated medical testing services to more than 2,000 second-tier and above hospitals, as well as over 500 tertiary-level medical institutions, earning a strong reputation for professionalism
Research background
As domestic healthcare reforms advance and hospital operational efficiency demands increase, third-party medical testing services—acting as a key complement to professional specialization—are increasingly becoming a strategic choice for hospitals seeking to enhance service capabilities and control costs. Building upon its existing partnerships, Hehe Diagnostics aims to expand its market share and explore potential collaborations with additional regional and medical institutions. To scientifically assess the market size and feasibility of future expansion, the company urgently requires a systematic research effort to understand industry trends, regional demand variations, and client decision-making mechanisms, thereby optimizing its expansion strategy
Research scope
In November 2019, CEIDEA Research was commissioned by Hehe Diagnostics to conduct a specialized study on the current state and potential of the third-party medical detection market. This research focuses on second- and third-tier medical institutions, employing a combination of in-depth interviews and quantitative surveys to examine hospitals' acceptance of outsourced testing services, current partnership status, potential collaboration needs, and key decision-making processes. The study covers key regions including East China, South China, and North China. It aims to comprehensively evaluate the feasibility and risk management strategies for Hehe Diagnostics' future expansion, from policy environments, industry trends, service pain points, and competitive landscapes, providing actionable insights for the company's next phase of development
Expected outcomes
The research is expected to provide Hehe Diagnostics with a comprehensive market size assessment and regional potential analysis, helping the company identify key priority regions and target institution types for market expansion. It will also clarify the key barriers and enablers in advancing third-party partnerships. By gaining deep insights into competitive dynamics and customer needs, the study will provide empirical support for the development of targeted market entry and client acquisition strategies, enabling Hehe Diagnostics to achieve sustainable growth and continuous market share expansion in the future
Scan to add our research consultant